BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2531 hits Enz. Inhib. hit(s) with Target = 'NS3/4A protease'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244632
PNG
(US10226449, cpd 241 | US9428502, 241)
Show SMILES Cc1ccc(cc1-c1[nH]c(nc1Cl)C1CCOCC1)C(=O)N1CC(C1)c1ccc(cc1)C#N
Show InChI InChI=1S/C26H25ClN4O2/c1-16-2-5-20(26(32)31-14-21(15-31)18-6-3-17(13-28)4-7-18)12-22(16)23-24(27)30-25(29-23)19-8-10-33-11-9-19/h2-7,12,19,21H,8-11,14-15H2,1H3,(H,29,30)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244736
PNG
(US10226449, cpd 346 | US9428502, 346)
Show SMILES Cc1ccc(cc1-c1[nH]c(nc1Cl)C1(C)CCOCC1)C(=O)N1CC(C1)c1ccc(cc1)C#N
Show InChI InChI=1S/C27H27ClN4O2/c1-17-3-6-20(25(33)32-15-21(16-32)19-7-4-18(14-29)5-8-19)13-22(17)23-24(28)31-26(30-23)27(2)9-11-34-12-10-27/h3-8,13,21H,9-12,15-16H2,1-2H3,(H,30,31)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.100n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229593
PNG
(US9334279, 1069)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ncccc1Cl)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C34H45ClF3N5O8S/c1-19-9-6-7-10-21-17-33(21,29(46)42-52(48,49)32(5)12-13-32)41-26(44)24-16-22(50-27-23(35)11-8-14-39-27)18-43(24)28(45)25(20(2)15-19)40-30(47)51-31(3,4)34(36,37)38/h7-8,10-11,14,19-22,24-25H,6,9,12-13,15-18H2,1-5H3,(H,40,47)(H,41,44)(H,42,46)/b10-7-/t19-,20-,21-,22-,24+,25+,33-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229591
PNG
(US9334279, 1067)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1nccc(Cl)c1C(F)(F)F)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C35H44ClF6N5O8S/c1-18-8-6-7-9-20-16-33(20,29(50)46-56(52,53)32(5)11-12-32)45-26(48)23-15-21(54-27-24(34(37,38)39)22(36)10-13-43-27)17-47(23)28(49)25(19(2)14-18)44-30(51)55-31(3,4)35(40,41)42/h7,9-10,13,18-21,23,25H,6,8,11-12,14-17H2,1-5H3,(H,44,51)(H,45,48)(H,46,50)/b9-7-/t18-,19-,20-,21-,23+,25+,33-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229588
PNG
(US9334279, 1064)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ccc(cn1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C37H47F3N6O8S2/c1-21-8-6-7-9-24-18-36(24,32(49)45-56(51,52)35(5)12-13-35)44-29(47)26-17-25(53-27-11-10-23(19-42-27)30-41-14-15-55-30)20-46(26)31(48)28(22(2)16-21)43-33(50)54-34(3,4)37(38,39)40/h7,9-11,14-15,19,21-22,24-26,28H,6,8,12-13,16-18,20H2,1-5H3,(H,43,50)(H,44,47)(H,45,49)/b9-7-/t21-,22-,24-,25-,26+,28+,36-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229584
PNG
(US9334279, 1060)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1ccccc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C43H51F3N6O8S2/c1-25-11-9-10-14-28-23-42(28,38(55)51-62(57,58)41(5)15-16-41)50-35(53)33-22-30(24-52(33)37(54)34(26(2)19-25)49-39(56)60-40(3,4)43(44,45)46)59-29-20-31(27-12-7-6-8-13-27)48-32(21-29)36-47-17-18-61-36/h6-8,10,12-14,17-18,20-21,25-26,28,30,33-34H,9,11,15-16,19,22-24H2,1-5H3,(H,49,56)(H,50,53)(H,51,55)/b14-10-/t25-,26-,28-,30-,33+,34+,42-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229576
PNG
(US9334279, 1052)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cscn1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-20-34(21-37(53-36)38-25-68-27-52-38)66-35-22-39-41(58)55-47(43(60)56-69(62,63)45(5)16-17-45)23-32(47)10-7-6-9-29(3)19-30(4)40(42(59)57(39)24-35)54-44(61)67-46(48(49,50)51)15-8-18-64-26-46/h7,10-14,20-21,25,27-30,32,35,39-40H,6,8-9,15-19,22-24,26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,39+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229575
PNG
(US9334279, 1051)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1ccccn1
Show InChI InChI=1/C50H61F3N6O10S/c1-30(2)67-35-16-14-33(15-17-35)39-24-36(25-40(55-39)38-13-8-9-21-54-38)68-37-26-41-43(60)57-49(45(62)58-70(64,65)47(5)19-20-47)27-34(49)12-7-6-11-31(3)23-32(4)42(44(61)59(41)28-37)56-46(63)69-48(50(51,52)53)18-10-22-66-29-48/h7-9,12-17,21,24-25,30-32,34,37,41-42H,6,10-11,18-20,22-23,26-29H2,1-5H3,(H,56,63)(H,57,60)(H,58,62)/b12-7-/t31-,32-,34-,37-,41+,42+,48?,49-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229574
PNG
(US9334279, 1050)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1cccnc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C42H50F3N7O8S2/c1-24-9-6-7-11-27-21-41(27,37(55)51-62(57,58)40(5)12-13-40)50-34(53)32-20-29(23-52(32)36(54)33(25(2)17-24)49-38(56)60-39(3,4)42(43,44)45)59-28-18-30(26-10-8-14-46-22-26)48-31(19-28)35-47-15-16-61-35/h7-8,10-11,14-16,18-19,22,24-25,27,29,32-33H,6,9,12-13,17,20-21,23H2,1-5H3,(H,49,56)(H,50,53)(H,51,55)/b11-7-/t24-,25-,27-,29-,32+,33+,41-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229569
PNG
(US9334279, 1045)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ccnc(c1)-c1nc(C)cs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C38H49F3N6O8S2/c1-21-9-7-8-10-24-18-37(24,33(50)46-57(52,53)36(6)12-13-36)45-30(48)28-17-26(54-25-11-14-42-27(16-25)31-43-23(3)20-56-31)19-47(28)32(49)29(22(2)15-21)44-34(51)55-35(4,5)38(39,40)41/h8,10-11,14,16,20-22,24,26,28-29H,7,9,12-13,15,17-19H2,1-6H3,(H,44,51)(H,45,48)(H,46,50)/b10-8-/t21-,22-,24-,26-,28+,29+,37-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229567
PNG
(US9334279, 1043)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ccnc(c1)-c1ncc(C)s1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C38H49F3N6O8S2/c1-21-9-7-8-10-24-18-37(24,33(50)46-57(52,53)36(6)12-13-36)45-30(48)28-17-26(54-25-11-14-42-27(16-25)31-43-19-23(3)56-31)20-47(28)32(49)29(22(2)15-21)44-34(51)55-35(4,5)38(39,40)41/h8,10-11,14,16,19,21-22,24,26,28-29H,7,9,12-13,15,17-18,20H2,1-6H3,(H,44,51)(H,45,48)(H,46,50)/b10-8-/t21-,22-,24-,26-,28+,29+,37-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229564
PNG
(US9334279, 1040)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(cc1)C(F)(F)F)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C46H52F6N6O10S2/c1-4-35-36(55-41(62)68-43(46(50,51)52)14-7-18-65-25-43)39(60)58-24-31(67-30-20-32(54-33(21-30)38-53-17-19-69-38)27-10-12-28(13-11-27)45(47,48)49)22-34(58)37(59)56-44(23-29(44)9-6-5-8-26(2)66-35)40(61)57-70(63,64)42(3)15-16-42/h6,9-13,17,19-21,26,29,31,34-36H,4-5,7-8,14-16,18,22-25H2,1-3H3,(H,55,62)(H,56,59)(H,57,61)/b9-6-/t26-,29-,31-,34+,35+,36+,43?,44-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229561
PNG
(US9334279, 1037)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccccn1)-c1ccc(OC(C)C)cc1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C50H61F3N6O11S/c1-6-41-42(56-46(63)70-48(50(51,52)53)19-11-23-66-29-48)44(61)59-28-36(69-35-24-38(32-15-17-34(18-16-32)67-30(2)3)55-39(25-35)37-14-9-10-22-54-37)26-40(59)43(60)57-49(27-33(49)13-8-7-12-31(4)68-41)45(62)58-71(64,65)47(5)20-21-47/h8-10,13-18,22,24-25,30-31,33,36,40-42H,6-7,11-12,19-21,23,26-29H2,1-5H3,(H,56,63)(H,57,60)(H,58,62)/b13-8-/t31-,33-,36-,40+,41+,42+,48?,49-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229560
PNG
(US9334279, 1036)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1cscn1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C48H59F3N6O11S2/c1-6-39-40(54-44(61)68-46(48(49,50)51)16-9-19-64-26-46)42(59)57-24-34(67-33-20-35(53-36(21-33)37-25-69-27-52-37)30-12-14-32(15-13-30)65-28(2)3)22-38(57)41(58)55-47(23-31(47)11-8-7-10-29(4)66-39)43(60)56-70(62,63)45(5)17-18-45/h8,11-15,20-21,25,27-29,31,34,38-40H,6-7,9-10,16-19,22-24,26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b11-8-/t29-,31-,34-,38+,39+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.300n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229547
PNG
(US9334279, 1023)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1nccs1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C40H48F3N7O8S3/c1-22-8-6-7-9-24-20-39(24,35(53)49-61(55,56)38(5)10-11-38)48-31(51)29-19-26(57-25-17-27(32-44-12-14-59-32)46-28(18-25)33-45-13-15-60-33)21-50(29)34(52)30(23(2)16-22)47-36(54)58-37(3,4)40(41,42)43/h7,9,12-15,17-18,22-24,26,29-30H,6,8,10-11,16,19-21H2,1-5H3,(H,47,54)(H,48,51)(H,49,53)/b9-7-/t22-,23-,24-,26-,29+,30+,39-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.400n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229547
PNG
(US9334279, 1023)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1nccs1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C40H48F3N7O8S3/c1-22-8-6-7-9-24-20-39(24,35(53)49-61(55,56)38(5)10-11-38)48-31(51)29-19-26(57-25-17-27(32-44-12-14-59-32)46-28(18-25)33-45-13-15-60-33)21-50(29)34(52)30(23(2)16-22)47-36(54)58-37(3,4)40(41,42)43/h7,9,12-15,17-18,22-24,26,29-30H,6,8,10-11,16,19-21H2,1-5H3,(H,47,54)(H,48,51)(H,49,53)/b9-7-/t22-,23-,24-,26-,29+,30+,39-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.460n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229525
PNG
(US9334279, 1001)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cnccn1
Show InChI InChI=1/C47H58F3N7O9S/c1-27(2)64-32-14-12-30(13-15-32)35-21-33(22-36(53-35)37-25-51-18-19-52-37)65-34-23-38-40(58)55-46(42(60)56-67(62,63)45(7)16-17-45)24-31(46)11-9-8-10-28(3)20-29(4)39(41(59)57(38)26-34)54-43(61)66-44(5,6)47(48,49)50/h9,11-15,18-19,21-22,25,27-29,31,34,38-39H,8,10,16-17,20,23-24,26H2,1-7H3,(H,54,61)(H,55,58)(H,56,60)/b11-9-/t28-,29-,31-,34-,38+,39+,46-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229568
PNG
(US9334279, 1044)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C1)Oc1ccnc(c1)-c1ncc(C)s1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C40H51F3N6O9S2/c1-23-8-5-6-9-26-19-39(26,35(52)48-60(54,55)37(4)12-13-37)47-32(50)30-18-28(57-27-10-14-44-29(17-27)33-45-20-25(3)59-33)21-49(30)34(51)31(24(2)16-23)46-36(53)58-38(40(41,42)43)11-7-15-56-22-38/h6,9-10,14,17,20,23-24,26,28,30-31H,5,7-8,11-13,15-16,18-19,21-22H2,1-4H3,(H,46,53)(H,47,50)(H,48,52)/b9-6-/t23-,24-,26-,28-,30+,31+,38?,39-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229571
PNG
(US9334279, 1047)
Show SMILES CC(C)Oc1ccc(cn1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1nccs1
Show InChI InChI=1/C47H58F3N7O10S2/c1-27(2)65-37-12-11-30(24-52-37)34-20-32(21-35(53-34)40-51-16-18-68-40)66-33-22-36-39(58)55-46(42(60)56-69(62,63)44(5)14-15-44)23-31(46)10-7-6-9-28(3)19-29(4)38(41(59)57(36)25-33)54-43(61)67-45(47(48,49)50)13-8-17-64-26-45/h7,10-12,16,18,20-21,24,27-29,31,33,36,38H,6,8-9,13-15,17,19,22-23,25-26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t28-,29-,31-,33-,36+,38+,45?,46-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229545
PNG
(US9334279, 1021)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1ccccn1
Show InChI InChI=1/C48H59F3N6O9S/c1-28(2)64-33-17-15-31(16-18-33)37-23-34(24-38(53-37)36-14-10-11-21-52-36)65-35-25-39-41(58)55-47(43(60)56-67(62,63)46(7)19-20-46)26-32(47)13-9-8-12-29(3)22-30(4)40(42(59)57(39)27-35)54-44(61)66-45(5,6)48(49,50)51/h9-11,13-18,21,23-24,28-30,32,35,39-40H,8,12,19-20,22,25-27H2,1-7H3,(H,54,61)(H,55,58)(H,56,60)/b13-9-/t29-,30-,32-,35-,39+,40+,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229555
PNG
(US9334279, 1031 | US9334279, 1062)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(ccn1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C37H47F3N6O8S2/c1-21-8-6-7-9-24-19-36(24,32(49)45-56(51,52)35(5)11-12-35)44-29(47)26-18-25(53-27-17-23(10-13-41-27)30-42-14-15-55-30)20-46(26)31(48)28(22(2)16-21)43-33(50)54-34(3,4)37(38,39)40/h7,9-10,13-15,17,21-22,24-26,28H,6,8,11-12,16,18-20H2,1-5H3,(H,43,50)(H,44,47)(H,45,49)/b9-7-/t21-,22-,24-,25-,26+,28+,36-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229565
PNG
(US9334279, 1041)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1nccs1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-22-34(23-37(53-36)41-52-18-20-68-41)66-35-24-38-40(58)55-47(43(60)56-69(62,63)45(5)16-17-45)25-32(47)10-7-6-9-29(3)21-30(4)39(42(59)57(38)26-35)54-44(61)67-46(48(49,50)51)15-8-19-64-27-46/h7,10-14,18,20,22-23,28-30,32,35,38-39H,6,8-9,15-17,19,21,24-27H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,38+,39+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229567
PNG
(US9334279, 1043)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ccnc(c1)-c1ncc(C)s1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C38H49F3N6O8S2/c1-21-9-7-8-10-24-18-37(24,33(50)46-57(52,53)36(6)12-13-36)45-30(48)28-17-26(54-25-11-14-42-27(16-25)31-43-19-23(3)56-31)20-47(28)32(49)29(22(2)15-21)44-34(51)55-35(4,5)38(39,40)41/h8,10-11,14,16,19,21-22,24,26,28-29H,7,9,12-13,15,17-18,20H2,1-6H3,(H,44,51)(H,45,48)(H,46,50)/b10-8-/t21-,22-,24-,26-,28+,29+,37-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229557
PNG
(US9334279, 1033)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC(C)(C)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1cncs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C46H57F3N6O10S2/c1-8-36-38(52-42(59)65-43(5,6)46(47,48)49)40(57)55-24-32(64-31-19-33(51-34(20-31)37-23-50-25-66-37)28-13-15-30(16-14-28)62-26(2)3)21-35(55)39(56)53-45(22-29(45)12-10-9-11-27(4)63-36)41(58)54-67(60,61)44(7)17-18-44/h10,12-16,19-20,23,25-27,29,32,35-36,38H,8-9,11,17-18,21-22,24H2,1-7H3,(H,52,59)(H,53,56)(H,54,58)/b12-10-/t27-,29-,32-,35+,36+,38+,45-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229576
PNG
(US9334279, 1052)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cscn1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-20-34(21-37(53-36)38-25-68-27-52-38)66-35-22-39-41(58)55-47(43(60)56-69(62,63)45(5)16-17-45)23-32(47)10-7-6-9-29(3)19-30(4)40(42(59)57(39)24-35)54-44(61)67-46(48(49,50)51)15-8-18-64-26-46/h7,10-14,20-21,25,27-30,32,35,39-40H,6,8-9,15-19,22-24,26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,39+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229578
PNG
(US9334279, 1054)
Show SMILES CC[C@@H]1C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(cc1)C(F)(F)F)-c1nccs1)C(=O)NS(=O)(=O)C1CC1
Show InChI InChI=1/C46H52F6N6O9S2/c1-3-27-19-26(2)7-4-5-8-30-23-44(30,41(61)57-69(63,64)33-13-14-33)56-38(59)36-22-32(24-58(36)40(60)37(27)55-42(62)67-43(46(50,51)52)15-6-17-65-25-43)66-31-20-34(54-35(21-31)39-53-16-18-68-39)28-9-11-29(12-10-28)45(47,48)49/h5,8-12,16,18,20-21,26-27,30,32-33,36-37H,3-4,6-7,13-15,17,19,22-25H2,1-2H3,(H,55,62)(H,56,59)(H,57,61)/b8-5-/t26-,27-,30-,32-,36+,37+,43?,44-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229583
PNG
(US9334279, 1059)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1ccc(C)cc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C44H53F3N6O8S2/c1-25-11-13-28(14-12-25)32-20-30(21-33(49-32)37-48-17-18-62-37)60-31-22-34-36(54)51-43(39(56)52-63(58,59)42(6)15-16-42)23-29(43)10-8-7-9-26(2)19-27(3)35(38(55)53(34)24-31)50-40(57)61-41(4,5)44(45,46)47/h8,10-14,17-18,20-21,26-27,29,31,34-35H,7,9,15-16,19,22-24H2,1-6H3,(H,50,57)(H,51,54)(H,52,56)/b10-8-/t26-,27-,29-,31-,34+,35+,43-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229583
PNG
(US9334279, 1059)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1ccc(C)cc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C44H53F3N6O8S2/c1-25-11-13-28(14-12-25)32-20-30(21-33(49-32)37-48-17-18-62-37)60-31-22-34-36(54)51-43(39(56)52-63(58,59)42(6)15-16-42)23-29(43)10-8-7-9-26(2)19-27(3)35(38(55)53(34)24-31)50-40(57)61-41(4,5)44(45,46)47/h8,10-14,17-18,20-21,26-27,29,31,34-35H,7,9,15-16,19,22-24H2,1-6H3,(H,50,57)(H,51,54)(H,52,56)/b10-8-/t26-,27-,29-,31-,34+,35+,43-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229584
PNG
(US9334279, 1060)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1ccccc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C43H51F3N6O8S2/c1-25-11-9-10-14-28-23-42(28,38(55)51-62(57,58)41(5)15-16-41)50-35(53)33-22-30(24-52(33)37(54)34(26(2)19-25)49-39(56)60-40(3,4)43(44,45)46)59-29-20-31(27-12-7-6-8-13-27)48-32(21-29)36-47-17-18-61-36/h6-8,10,12-14,17-18,20-21,25-26,28,30,33-34H,9,11,15-16,19,22-24H2,1-5H3,(H,49,56)(H,50,53)(H,51,55)/b14-10-/t25-,26-,28-,30-,33+,34+,42-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229555
PNG
(US9334279, 1031 | US9334279, 1062)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(ccn1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C37H47F3N6O8S2/c1-21-8-6-7-9-24-19-36(24,32(49)45-56(51,52)35(5)11-12-35)44-29(47)26-18-25(53-27-17-23(10-13-41-27)30-42-14-15-55-30)20-46(26)31(48)28(22(2)16-21)43-33(50)54-34(3,4)37(38,39)40/h7,9-10,13-15,17,21-22,24-26,28H,6,8,11-12,16,18-20H2,1-5H3,(H,43,50)(H,44,47)(H,45,49)/b9-7-/t21-,22-,24-,25-,26+,28+,36-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229565
PNG
(US9334279, 1041)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1nccs1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-22-34(23-37(53-36)41-52-18-20-68-41)66-35-24-38-40(58)55-47(43(60)56-69(62,63)45(5)16-17-45)25-32(47)10-7-6-9-29(3)21-30(4)39(42(59)57(38)26-35)54-44(61)67-46(48(49,50)51)15-8-19-64-27-46/h7,10-14,18,20,22-23,28-30,32,35,38-39H,6,8-9,15-17,19,21,24-27H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,38+,39+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229549
PNG
(US9334279, 1025)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ccnc(c1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C37H47F3N6O8S2/c1-21-8-6-7-9-23-19-36(23,32(49)45-56(51,52)35(5)11-12-35)44-29(47)27-18-25(53-24-10-13-41-26(17-24)30-42-14-15-55-30)20-46(27)31(48)28(22(2)16-21)43-33(50)54-34(3,4)37(38,39)40/h7,9-10,13-15,17,21-23,25,27-28H,6,8,11-12,16,18-20H2,1-5H3,(H,43,50)(H,44,47)(H,45,49)/b9-7-/t21-,22-,23-,25-,27+,28+,36-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229564
PNG
(US9334279, 1040)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(cc1)C(F)(F)F)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C46H52F6N6O10S2/c1-4-35-36(55-41(62)68-43(46(50,51)52)14-7-18-65-25-43)39(60)58-24-31(67-30-20-32(54-33(21-30)38-53-17-19-69-38)27-10-12-28(13-11-27)45(47,48)49)22-34(58)37(59)56-44(23-29(44)9-6-5-8-26(2)66-35)40(61)57-70(63,64)42(3)15-16-42/h6,9-13,17,19-21,26,29,31,34-36H,4-5,7-8,14-16,18,22-25H2,1-3H3,(H,55,62)(H,56,59)(H,57,61)/b9-6-/t26-,29-,31-,34+,35+,36+,43?,44-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229562
PNG
(US9334279, 1038)
Show SMILES CC[C@@H]1OCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1cncs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C47H57F3N6O11S2/c1-5-37-39(53-43(60)67-45(47(48,49)50)15-9-18-63-26-45)41(58)56-25-33(66-32-20-34(52-35(21-32)38-24-51-27-68-38)29-11-13-31(14-12-29)65-28(2)3)22-36(56)40(57)54-46(23-30(46)10-7-6-8-19-64-37)42(59)55-69(61,62)44(4)16-17-44/h7,10-14,20-21,24,27-28,30,33,36-37,39H,5-6,8-9,15-19,22-23,25-26H2,1-4H3,(H,53,60)(H,54,57)(H,55,59)/b10-7-/t30-,33-,36+,37+,39+,45?,46-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229590
PNG
(US9334279, 1066)
Show SMILES C[C@@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1ncccc1C(F)(F)F)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C35H45F6N5O8S/c1-19-9-6-7-10-21-17-33(21,29(49)45-55(51,52)32(5)12-13-32)44-26(47)24-16-22(53-27-23(34(36,37)38)11-8-14-42-27)18-46(24)28(48)25(20(2)15-19)43-30(50)54-31(3,4)35(39,40)41/h7-8,10-11,14,19-22,24-25H,6,9,12-13,15-18H2,1-5H3,(H,43,50)(H,44,47)(H,45,49)/b10-7-/t19-,20-,21-,22-,24+,25+,33-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229548
PNG
(US9334279, 1024)
Show SMILES C[C@H]1CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C1)Oc1cc(nc(c1)-c1nccs1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C40H48F3N7O8S3/c1-22-8-6-7-9-24-20-39(24,35(53)49-61(55,56)38(5)10-11-38)48-31(51)29-19-26(57-25-17-27(32-44-12-14-59-32)46-28(18-25)33-45-13-15-60-33)21-50(29)34(52)30(23(2)16-22)47-36(54)58-37(3,4)40(41,42)43/h7,9,12-15,17-18,22-24,26,29-30H,6,8,10-11,16,19-21H2,1-5H3,(H,47,54)(H,48,51)(H,49,53)/b9-7-/t22-,23+,24+,26+,29-,30-,39+/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229560
PNG
(US9334279, 1036)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1cscn1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C48H59F3N6O11S2/c1-6-39-40(54-44(61)68-46(48(49,50)51)16-9-19-64-26-46)42(59)57-24-34(67-33-20-35(53-36(21-33)37-25-69-27-52-37)30-12-14-32(15-13-30)65-28(2)3)22-38(57)41(58)55-47(23-31(47)11-8-7-10-29(4)66-39)43(60)56-70(62,63)45(5)17-18-45/h8,11-15,20-21,25,27-29,31,34,38-40H,6-7,9-10,16-19,22-24,26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b11-8-/t29-,31-,34-,38+,39+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229559
PNG
(US9334279, 1035)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C48H59F3N6O11S2/c1-6-38-39(54-44(61)68-46(48(49,50)51)16-9-20-64-27-46)42(59)57-26-34(67-33-22-35(53-36(23-33)41-52-19-21-69-41)30-12-14-32(15-13-30)65-28(2)3)24-37(57)40(58)55-47(25-31(47)11-8-7-10-29(4)66-38)43(60)56-70(62,63)45(5)17-18-45/h8,11-15,19,21-23,28-29,31,34,37-39H,6-7,9-10,16-18,20,24-27H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b11-8-/t29-,31-,34-,37+,38+,39+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229559
PNG
(US9334279, 1035)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1nccs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C48H59F3N6O11S2/c1-6-38-39(54-44(61)68-46(48(49,50)51)16-9-20-64-27-46)42(59)57-26-34(67-33-22-35(53-36(23-33)41-52-19-21-69-41)30-12-14-32(15-13-30)65-28(2)3)24-37(57)40(58)55-47(25-31(47)11-8-7-10-29(4)66-38)43(60)56-70(62,63)45(5)17-18-45/h8,11-15,19,21-23,28-29,31,34,37-39H,6-7,9-10,16-18,20,24-27H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b11-8-/t29-,31-,34-,37+,38+,39+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229558
PNG
(US9334279, 1034)
Show SMILES CC[C@@H]1O[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H]1NC(=O)OC1(CCCOC1)C(F)(F)F)Oc1cc(nc(c1)-c1ccc(OC(C)C)cc1)-c1cncs1)C(=O)NS(=O)(=O)C1(C)CC1
Show InChI InChI=1/C48H59F3N6O11S2/c1-6-38-40(54-44(61)68-46(48(49,50)51)16-9-19-64-26-46)42(59)57-25-34(67-33-20-35(53-36(21-33)39-24-52-27-69-39)30-12-14-32(15-13-30)65-28(2)3)22-37(57)41(58)55-47(23-31(47)11-8-7-10-29(4)66-38)43(60)56-70(62,63)45(5)17-18-45/h8,11-15,20-21,24,27-29,31,34,37-38,40H,6-7,9-10,16-19,22-23,25-26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b11-8-/t29-,31-,34-,37+,38+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.75n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229541
PNG
(US9334279, 1017)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cncs1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-20-34(21-37(53-36)39-24-52-27-68-39)66-35-22-38-41(58)55-47(43(60)56-69(62,63)45(5)16-17-45)23-32(47)10-7-6-9-29(3)19-30(4)40(42(59)57(38)25-35)54-44(61)67-46(48(49,50)51)15-8-18-64-26-46/h7,10-14,20-21,24,27-30,32,35,38,40H,6,8-9,15-19,22-23,25-26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,38+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.820n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229541
PNG
(US9334279, 1017)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC2(CCCOC2)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cncs1
Show InChI InChI=1/C48H59F3N6O10S2/c1-28(2)65-33-13-11-31(12-14-33)36-20-34(21-37(53-36)39-24-52-27-68-39)66-35-22-38-41(58)55-47(43(60)56-69(62,63)45(5)16-17-45)23-32(47)10-7-6-9-29(3)19-30(4)40(42(59)57(38)25-35)54-44(61)67-46(48(49,50)51)15-8-18-64-26-46/h7,10-14,20-21,24,27-30,32,35,38,40H,6,8-9,15-19,22-23,25-26H2,1-5H3,(H,54,61)(H,55,58)(H,56,60)/b10-7-/t29-,30-,32-,35-,38+,40+,46?,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.950n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244563
PNG
(US10226449, cpd 172 | US9428502, 172)
Show SMILES Cc1nc([nH]c1-c1cc(ccc1C)C(=O)N1CC(C1)c1ccc(cc1)C#N)C1CCOC1
Show InChI InChI=1/C26H26N4O2/c1-16-3-6-20(11-23(16)24-17(2)28-25(29-24)21-9-10-32-15-21)26(31)30-13-22(14-30)19-7-4-18(12-27)5-8-19/h3-8,11,21-22H,9-10,13-15H2,1-2H3,(H,28,29)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
HCV NS3-NS4A Serine Proteinase


(Hepatitis C virus (HCV genotype 1a, isolate H))
BDBM65581
PNG
(US9693997, 1)
Show SMILES CC(C)(C)OC(=O)N1CCC(CC1)S(=O)(=O)c1ccc(cc1)-c1c(Cl)cc(Nc2n[nH]c(N)n2)cc1C(F)(F)F
Show InChI InChI=1S/C25H28ClF3N6O4S/c1-24(2,3)39-23(36)35-10-8-17(9-11-35)40(37,38)16-6-4-14(5-7-16)20-18(25(27,28)29)12-15(13-19(20)26)31-22-32-21(30)33-34-22/h4-7,12-13,17H,8-11H2,1-3H3,(H4,30,31,32,33,34)
PDB
MMDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1n/an/an/an/a



Hoffmann-La Roche Inc

US Patent


Assay Description
Plasmids expressing HCV E1 and E2 envelope proteins of GT1a H77 strain (Proc Natl Acad Sci USA 1997 94:8738-43) or GT1b Con1 strain (Science 1999 285...


US Patent US9693997 (2017)


BindingDB Entry DOI: 10.7270/Q2833Q56
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244629
PNG
(US10226449, cpd 238 | US9428502, 238)
Show SMILES Cc1ccc(cc1-c1[nH]c(nc1CO)C1CC1)C(=O)N1CC(C1)c1ccc(cc1)C#N
Show InChI InChI=1S/C25H24N4O2/c1-15-2-5-19(10-21(15)23-22(14-30)27-24(28-23)18-8-9-18)25(31)29-12-20(13-29)17-6-3-16(11-26)4-7-17/h2-7,10,18,20,30H,8-9,12-14H2,1H3,(H,27,28)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244568
PNG
(US10226449, cpd 177 | US9428502, 177)
Show SMILES Cc1nc([nH]c1-c1cc(ccc1C)C(=O)N1CC(C1)c1ccc(cc1)C#N)C1(C)COC1
Show InChI InChI=1S/C26H26N4O2/c1-16-4-7-20(10-22(16)23-17(2)28-25(29-23)26(3)14-32-15-26)24(31)30-12-21(13-30)19-8-5-18(11-27)6-9-19/h4-10,21H,12-15H2,1-3H3,(H,28,29)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1a (strain H77) (HCV))
BDBM229529
PNG
(US9334279, 1005)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cccnc1
Show InChI InChI=1/C48H59F3N6O9S/c1-28(2)64-34-16-14-31(15-17-34)37-22-35(23-38(53-37)32-12-10-20-52-26-32)65-36-24-39-41(58)55-47(43(60)56-67(62,63)46(7)18-19-46)25-33(47)13-9-8-11-29(3)21-30(4)40(42(59)57(39)27-36)54-44(61)66-45(5,6)48(49,50)51/h9-10,12-17,20,22-23,26,28-30,33,36,39-40H,8,11,18-19,21,24-25,27H2,1-7H3,(H,54,61)(H,55,58)(H,56,60)/b13-9-/t29-,30-,33-,36-,39+,40+,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.48n/an/an/a37



Bristol-Myers Squibb Co.

US Patent


Assay Description
HCV replicon luciferase assays were developed to monitor the inhibitory effects of compounds described in the disclosure on HCV genotypes 1a and 1b v...


US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3/4A protease


(Hepatitis C virus genotype 1b (strain J4L2S) (HCV))
BDBM229529
PNG
(US9334279, 1005)
Show SMILES CC(C)Oc1ccc(cc1)-c1cc(O[C@@H]2C[C@@H]3N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C(F)(F)F)[C@H](C)C[C@H](C)CC\C=C/[C@@H]2C[C@]2(NC3=O)C(=O)NS(=O)(=O)C2(C)CC2)cc(n1)-c1cccnc1
Show InChI InChI=1/C48H59F3N6O9S/c1-28(2)64-34-16-14-31(15-17-34)37-22-35(23-38(53-37)32-12-10-20-52-26-32)65-36-24-39-41(58)55-47(43(60)56-67(62,63)46(7)18-19-46)25-33(47)13-9-8-11-29(3)21-30(4)40(42(59)57(39)27-36)54-44(61)66-45(5,6)48(49,50)51/h9-10,12-17,20,22-23,26,28-30,33,36,39-40H,8,11,18-19,21,24-25,27H2,1-7H3,(H,54,61)(H,55,58)(H,56,60)/b13-9-/t29-,30-,33-,36-,39+,40+,47-/s2
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.71n/an/an/an/a



Bristol-Myers Squibb Co.

US Patent




US Patent US9334279 (2016)


BindingDB Entry DOI: 10.7270/Q2BR8R1W
More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244738
PNG
(US10226449, cpd 348 | US9428502, 348)
Show SMILES COC(=O)N1CCC(C)(CC1)c1nc(Cl)c([nH]1)-c1cc(ccc1C)C(=O)N1CC(C1)c1ccc(cc1)C#N
Show InChI InChI=1S/C29H30ClN5O3/c1-18-4-7-21(26(36)35-16-22(17-35)20-8-5-19(15-31)6-9-20)14-23(18)24-25(30)33-27(32-24)29(2)10-12-34(13-11-29)28(37)38-3/h4-9,14,22H,10-13,16-17H2,1-3H3,(H,32,33)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
NS3 serine protease (NS3)


(Hepatitis C Virus (Virus))
BDBM244436
PNG
(US10226449, cpd 45 | US9428502, 45)
Show SMILES CC(C)c1nc(Cl)c([nH]1)-c1cc(ccc1C)C(=O)N1CC(C1)c1ccc(cc1)C#N
Show InChI InChI=1S/C24H23ClN4O/c1-14(2)23-27-21(22(25)28-23)20-10-18(7-4-15(20)3)24(30)29-12-19(13-29)17-8-5-16(11-26)6-9-17/h4-10,14,19H,12-13H2,1-3H3,(H,27,28)
PDB

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2n/an/an/an/a



3-V Biosciences, Inc.

US Patent


Assay Description
The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c...


US Patent US10226449 (2019)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 2531 total )  |  Next  |  Last  >>
Jump to: